SIA "BIOTEST"Active
Key figures
Ratios
2025Balance sheet structure
Dividends
calculatedPaid out in dividends approximately 76 273 € (67% of equity at the end of the previous year).
Low confidence: the company does not file a cash flow statement, so the amount is an estimate from changes in equity — it may also include other reductions of equity (e.g. a share capital reduction).
Summary of financial statements2014–2025
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||||||||
| Total current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47 922 | 84 054 | 149 985 | 113 366 | 96 276 |
| Total non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 79 215 |
| Total assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47 922 | 84 054 | 149 985 | 113 366 | 175 491 |
| Balance sheet — liabilities and equity | ||||||||||||
| Current liabilities | 0 | 100 | 150 | 200 | 250 | 300 | 350 | 400 | 7314 | 11 631 | 136 | 2527 |
| Non-current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 0 | 100 | 150 | 200 | 250 | 300 | 350 | 400 | 7314 | 11 631 | 136 | 2527 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | 0 | -100 | -50 | -50 | -50 | -50 | -50 | 47 872 | 29 218 | 103 320 | 99 907 | 136 007 |
| Total equity | 0 | -100 | -150 | -200 | -250 | -300 | -350 | 47 522 | 76 740 | 138 354 | 113 230 | 172 964 |
| Income statement | ||||||||||||
| Sales revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47 929 | 34 815 | 107 826 | 104 618 | 145 138 |
| Operating profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47 922 | 29 576 | 103 320 | 99 907 | 136 007 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47 922 | 29 576 | 103 320 | 99 907 | 136 792 |
| Profit before income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47 922 | 29 576 | 103 320 | 99 907 | 136 007 |
| Profit for the reporting year | 0 | -100 | -50 | -50 | -50 | -50 | -50 | 47 872 | 29 218 | 103 320 | 99 907 | 136 007 |
| Labour costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 955 | 1550 | 1551 | 3669 |
| Depreciation of non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 785 |
| Other indicators | ||||||||||||
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41 706 | 125 031 | 76 273 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Summary: SIA "BIOTEST"
Overview
SIA "BIOTEST" (reg. no. 41503052611) is a limited liability company. The company was registered in 2010 and has been in the register for 15 years. Registered address: Daugavpils, Andreja Pumpura iela 17.
Financial results
Revenue in 2025 was 145 138 €, up 38,7% on the previous year (104 618 €). This is the company's highest revenue among the published years (2014–2025). Net profit for 2025 was 136 007 € (93,7% of revenue). The company was profitable in 5 of the 12 published years. In 2025 the company had 2 employees. Revenue per employee was 72 569 €. At the end of 2025, total assets were 175 491 € and equity 172 964 € (98,6% of assets).
Management and owners
The company has one board member. The sole owner of the company is a private individual.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.